en

PRODUCT DETAIL

Sixmo 74,2 mg implantát

Code 2119D
MA number EU/1/19/1369/001
Product Form: imp 4x74,2 mg (vre.PET/LDPE/Al + 1x apl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 19 - ANTIDOTA, DETOXICANTIA
ATC:
N NERVOUS SYSTEM
N07 OTHER NERVOUS SYSTEM DRUGS
N07B DRUGS USED IN ADDICTIVE DISORDERS
N07BC Drugs used in opioid dependence
N07BC01 Buprenorphine
Shelf life: 48
Container: sachet PET/Al/LDPE
Route of admin.: Subcutaneous use
Prescription Status: Medicinal product subject to special medical prescription with skew blue stripe.
Legal basis: Article 8(3) application - known active substance
MA issued: 20.06.2019
Validity: 20.06.2024
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 15.07.2019
eu-flag.png sk-flag.png